A team of international collaborators under Sydney Vital’s Flagship 2, has won the 2nd prize in the 2nd International-Atom Indonesia Best Paper Awards 2018 (I-AIBPA 2018)
with their paper entitled “Evaluation of Kidney Dose in Neuro Endocrine Tumours patients after Peptide Receptor Radionuclide Therapy using Lu-DOTATATE”.
The 2nd international- Atom Indonesia Best Paper Awards are open to worldwide scientists and researchers, and it is endowed by Atom Indonesia, an International Journal related to nuclear science and technology and indexed by SCOPUS.
Only three winners are awarded from submissions worldwide. Winners are invited to received grants at the 60th anniversary of BATAN (National Nuclear Energy Agency of Indonesia) on December 5, 2018, which will be attended by the Minister of Research, Technology and Higher Education of the Indonesian Republic.
Sydney Vital would like to congratulate the awardees above and encourage them to continue their path towards more notable findings and achievements.